Drug search by name

Lenvima 4 MG Daily Dose and Arterial thromboembolism

Result of checking the interaction of drug Lenvima 4 MG Daily Dose and disease Arterial thromboembolism for safety when used together.

Check result:

Lenvima 4 MG Daily Dose <> Arterial thromboembolism

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

In clinical trials, arterial thromboembolic events were reported in patients treated with lenvatinib. It is recommended to discontinue lenvatinib following an arterial thrombotic event. Care should be exercised when resuming lenvatinib after an arterial thromboembolic event as its safety has not been established and its use has not been studied in patients who have had an arterial thromboembolic event within the previous 6 months.

Lenvima 4 MG Daily Dose

Generic Name: lenvatinib

Brand Name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose

Synonyms: Lenvima

What is Lenvima 4 MG Daily Dose?